Case of bullous pemphigoid following coronavirus disease 2019 vaccination JOURNAL OF DERMATOLOGY,48(12):E606-E607 2021(Dec.) Author:Nakamura, Kenta; Kosano, Megumi; Sakai, Yuzuki; Saito, Nana; Takazawa, Yuko; Omodaka, Toshikazu; Kiniwa, Yukiko; Okuyama, Ryuhei;
Case of annular pustular psoriasis/circinate erythematous psoriasis induced by hydroxychloroquine in a patient with systemic lupus erythematosus: Possible association with CARD-14 mutation JOURNAL OF DERMATOLOGY,48(9):E440-E442 2021(Sep.) Author:Midorikawa, Hirotaka; Kiniwa, Yukiko; Minagawa, Akane; Osawa, Kana; Shirai, Takushi; Sano, Tasuku; Nakamura, Kenta; Ashida, Atsuko; Ueno, Ken-ichi; Takeichi, Takuya; Akiyama, Masashi; Okuyama, Ryuhei;
CCL5 production by fibroblasts through a local renin-angiotensin system in malignant melanoma affects tumor immune responses J Cancer Res Clin Oncol .,147(7):1993-2001 2021(Jul.) Author:Kenta Nakamura , Yukiko Kiniwa , Ryuhei Okuyama
Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation BMC CANCER,21(1):287 2021 Author:Kiniwa, Yukiko; Nakamura, Kenta; Mikoshiba, Asuka; Ashida, Atsuko; Akiyama, Yasuyuki; Morimoto, Atsushi; Okuyama, Ryuhei; Keywords:BRAF; Circulating tumor cell; Melanoma; BRAF; MEK inhibitor; Heterogenous mutation;
Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma ARCHIVES OF DERMATOLOGICAL RESEARCH 2021 Author:Nakamura, Kenta; Ashida, Atsuko; Kiniwa, Yukiko; Okuyama, Ryuhei; Keywords:C-C motif chemokine 5; Chemokine; C-X-C motif chemokine ligand 12; Melanoma; PD-1;